Bausch + Lomb Corporation ( BLCO) - Key Metrics
BLCO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.97 | -$0.16 | $0.38 | $0.17 |
| 2025Q3 | $3.62 | -$0.08 | $0.39 | $0.18 |
| 2025Q2 | $3.61 | -$0.18 | $0.10 | -$0.15 |
| 2025Q1 | $3.22 | -$0.60 | -$0.07 | -$0.38 |
BLCO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -26.05 |
| 2025Q3 | ? | -47.66 |
| 2025Q2 | ? | -18.55 |
| 2025Q1 | ? | -6.03 |
BLCO
Price: $15.99
52 week price:
Earnings Per Share: -0.62 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Volume: 494000
Market Capitalization: 6.1 billion